De Novo device
Masimo SafetyNet
Masimo Corporation · Monitor For Opioid Induced Impairment Of Oxygenation (QVT, Class II) · First FDA decision Mar 31, 2023, newest Mar 31, 2023Anesthesia and patient monitoringCritical care and remote patient monitoring
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "Masimo SafetyNet"
MAUDE reports
0
Brand "Masimo SafetyNet", since 2015
PubMed studies
0
Mentioning "Masimo SafetyNet"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Masimo SafetyNet
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Masimo SafetyNetNew device typeBreakthroughDe Novo
DEN200011 · Decided Mar 31, 2023 · 1,136 days after receipt
Device type: Monitor For Opioid Induced Impairment Of Oxygenation (QVT) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Masimo SafetyNet", any status and sponsor, newest update first.
Masimo CorporationPublic (MASI)
NCT06217380 · 10 participants · Start Sep 20, 2023 · Primary completion Feb 15, 2024
Device: Masimo SafetyNet Alert (MSNA) · For: Opioid Use
Sites: Vanier, Canada
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Masimo SafetyNet", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QVT
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Masimo SafetyNet"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.